Metastatic breast cancer: focus on endocrine sensitivity

Lancet. 2016 Dec 17;388(10063):2961-2962. doi: 10.1016/S0140-6736(16)32418-7. Epub 2016 Nov 29.

Author

Massimo Cristofanilli¹

Affiliation

¹ Department of Medicine, Division of Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: massimo.cristofanilli@nm.org.

PMID: 27908455
DOI: 10.1016/S0140-6736(16)32418-7

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use*
Breast Neoplasms / drug therapy*
Humans

Substances

Antineoplastic Agents, Hormonal